Cape Town – A total of 3,105 new cases linked to Covid-19 have been identified in the country in the past 24 hours.
This brings the cumulative total of Covid-19 cases to 762,763, Health Minister Zweli Mkhize said in a statement on Friday.
We would like to point out that we have crossed the threshold of 3,000 new daily cases (2,514 new cases were identified on Thursday and 2,888 on Friday). Of these new cases, more than half (54.4%) are from the Eastern Cape, ”said Mkhize.
“We’re also concerned that the positivity is 12%, which is higher than ideal, which is 10% or less.
Sadly, 88 other Covid-19-related deaths have been reported: Eastern Cape 67, Free State 15, Gauteng 2, KwaZulu-Natal 1 and Western Cape 3.
That brings the total to 20,759 deaths. We have noted that the number of new deaths reported daily in the Eastern Cape is also increasing. ”
“ We offer our condolences to the loved ones of the deceased and thank the healthcare workers who cared for the deceased patients. ”
The number of recoveries now stands at 707,040, which translates into a recovery rate of 92.7%. The cumulative number of tests performed to date is 5,243,055, with 29,019 new tests performed since the last report.
The Proteas cricket team has been rocked by yet another positive Covid-19 test, the team’s second after the mandatory second round of Covid-19 testing.
The player, who was not named due to doctor / patient confidentiality, tested positive on Thursday and was separated from the squad.
Transport Minister Fikile Mbalula tested negative for Covid-19 after a health alert this week.
Mbalula said on Twitter he had been tested for the coronavirus after feeling unwell since Monday.
“(I) haven’t been feeling well since Monday. Did my Covid-19 (test and) results come back negative, ”he says.
Meanwhile, Gilead’s remdesivir should not be used for patients hospitalized with Covid-19, regardless of their medical condition, as there is no evidence that the drug improves survival or reduces the need for ventilation. a World Health Organization panel said on Friday.
“The panel found a lack of evidence that remdesivir improves important patient outcomes,” the guideline says.
“ Especially considering the costs and resource implications associated with remdesivir … the expert group felt that the onus should be to demonstrate efficacy, which is not established by the currently available data. . ”